Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.005 USD | -0.50% | +15.60% | -50.49% |
04-30 | Gritstone Bio, Inc. Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA Vaccine at ESCMID Global 2024 | CI |
04-29 | Gritstone Bio, Inc. Announces Board Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.49% | 108M | |
-2.35% | 89.33B | |
+4.08% | 41.19B | |
-14.80% | 31.87B | |
+53.68% | 24.52B | |
-13.92% | 15.68B | |
-8.63% | 12.34B | |
-40.39% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- GRTS Stock
- News Gritstone bio, Inc.
- Gritstone Bio Says Cancer Immunotherapies Showed 'Early Evidence of Efficacy' in Phase 1/2 Study; Shares Rise